BioAdvance

Pennsylvania
Firm Location:Pennsylvania • Princeton, New Jersey
Investor Firms That Co-Invest with BioAdvance
BioAdvance Team
Photo of Gregory Harriman, Partner at BioAdvance
Gregory Harriman
BioAdvance·Partner
Sweet spot: $3.3M
Range: $1.5M - $5.0M
Investors in Washington, Investors in Delaware, Investors in New York City, Investors in Maryland, Investors in Pennsylvania
Photo of Shahram Hejazi, Managing Director at BioAdvance
Shahram Hejazi
BioAdvance·Managing Director
Sweet spot: $3.3M
Range: $1.5M - $5.0M
Investors in Princeton (NJ)
Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Manufacturing (Series B), Investors in Diagnostics (Seed), Investors in Manufacturing (Series A), Investors in Medical Devices (Series B), Investors in Manufacturing (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Frederick Jones, Partner at BioAdvance
Frederick Jones
BioAdvance·Partner
Sweet spot: $3.3M
Range: $1.5M - $5.0M
Investors in Boston (MA), Investors in Pennsylvania
Photo of Barbara Schilberg, Managing Director at BioAdvance
Barbara Schilberg
BioAdvance·Managing Director
Sweet spot: $3.3M
Range: $1.5M - $5.0M
Investors in Pennsylvania
Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed)